Cannasoul Analytics

Medical Cannabis Analytics

Health Tech & Life Sciences
Active
Seed Caesarea, Israel Founded 2018
Website ↗ LinkedIn
Last updated 2026-06-18
Total raised
$4.0M
Last: 2023-11
Stage
Seed
Founded
2018
Headcount
15
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences

About

Cannasoul is an Israeli cannabis drug-discovery company developing therapeutics derived from natural compounds. Cannasoul's proprietary analytical platform, data-driven approach, knowhow, and clinical trial framework support active compound identification and development, from botanical extract through clinical approved formulation. Cannasoul has analyzed over 100 cannabinoids and 100 terpenes. The company's subsidiaries include MyPlant Bio, Psyga Bio, Nidra Logic, and CaVnox.

Funding history · 2 rounds · $4.0M total

2023-11
$4.0M
Synaptogenix
2018-07

Q&A

What is Cannasoul Analytics' primary focus?
Cannasoul Analytics is an Israeli cannabis drug-discovery company that develops therapeutics derived from natural compounds, focusing on medical cannabis analytics.
When was Cannasoul Analytics founded?
Cannasoul Analytics was founded in January 2018.
How many employees does Cannasoul Analytics have?
Cannasoul Analytics has 11-50 employees.
What is the total amount of funding Cannasoul Analytics has raised?
Cannasoul Analytics has raised a total of $4,000,000 USD.
Which investor participated in Cannasoul Analytics' November 2023 funding round?
In November 2023, Synaptogenix participated in a funding round for Cannasoul Analytics, contributing $4,000,000 USD.
Who are the co-founders of Cannasoul Analytics?
The co-founders of Cannasoul Analytics are Prof. David (Dedi) Meiri, who serves as CSO & Chairman, and Shmuel (Muli) Mandel, who is the CEO.
Does Cannasoul Analytics hold any patents?
Yes, Cannasoul Analytics holds one patent.
What are some of Cannasoul Analytics' subsidiaries?
Cannasoul Analytics' subsidiaries include MyPlant Bio, Psyga Bio, Nidra Logic, and CaVnox.

Team · 2

Prof. David (Dedi) Meiri
Founder · Co-founder, CSO & Chairman
Shmuel (Muli) Mandel
Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesHealthcareLaboratories
Business model
B2B

Highlights

1 Patents

Tags

pharmaceuticalsmedical-cannabisclinical-trialsdrug-discoverybiotechnologytherapeuticscannabis
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)